Your browser doesn't support javascript.
loading
Introducing or removing heparan sulfate binding sites does not alter brain uptake of the blood-brain barrier shuttle scFv8D3.
de la Rosa, Andrés; Metzendorf, Nicole G; Morrison, Jamie I; Faresjö, Rebecca; Rofo, Fadi; Petrovic, Alex; O'Callaghan, Paul; Syvänen, Stina; Hultqvist, Greta.
Afiliação
  • de la Rosa A; Protein Drug Design Group, Department of Pharmacy, Uppsala University, Uppsala, Sweden.
  • Metzendorf NG; Protein Drug Design Group, Department of Pharmacy, Uppsala University, Uppsala, Sweden.
  • Morrison JI; Protein Drug Design Group, Department of Pharmacy, Uppsala University, Uppsala, Sweden.
  • Faresjö R; Department of Public Health and Caring Sciences, Uppsala University, Uppsala, Sweden.
  • Rofo F; Protein Drug Design Group, Department of Pharmacy, Uppsala University, Uppsala, Sweden.
  • Petrovic A; Protein Drug Design Group, Department of Pharmacy, Uppsala University, Uppsala, Sweden.
  • O'Callaghan P; Department of Medical Cell Biology, Uppsala University, Uppsala, Sweden.
  • Syvänen S; Department of Public Health and Caring Sciences, Uppsala University, Uppsala, Sweden.
  • Hultqvist G; Protein Drug Design Group, Department of Pharmacy, Uppsala University, Uppsala, Sweden. greta.hultqvist@farmaci.uu.se.
Sci Rep ; 12(1): 21479, 2022 12 12.
Article em En | MEDLINE | ID: mdl-36509864
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Encéfalo / Barreira Hematoencefálica Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Encéfalo / Barreira Hematoencefálica Idioma: En Ano de publicação: 2022 Tipo de documento: Article